{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:18:12Z","timestamp":1790338692925,"version":"4.1.0"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T00:00:00Z","timestamp":1544745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,6,18]]},"DOI":"10.1093\/ibd\/izy366","type":"journal-article","created":{"date-parts":[[2018,12,14]],"date-time":"2018-12-14T12:59:11Z","timestamp":1544792351000},"page":"1218-1226","source":"Crossref","is-referenced-by-count":33,"title":["Serologic Status of Routine Childhood Vaccines, Cytomegalovirus, and Epstein-Barr Virus in Children With Inflammatory Bowel Disease"],"prefix":"10.1093","volume":"25","author":[{"given":"Jennifer C C","family":"deBruyn","sequence":"first","affiliation":[{"name":"Section of Paediatric Gastroenterology, Department of Paediatrics, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ing Shian","family":"Soon","sequence":"additional","affiliation":[{"name":"Section of Paediatric Gastroenterology, Department of Paediatrics, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Fonseca","sequence":"additional","affiliation":[{"name":"Virology, Provincial Laboratory for Public Health, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Feng","sequence":"additional","affiliation":[{"name":"Section of Paediatric Gastroenterology, Department of Paediatrics, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Purtzki","sequence":"additional","affiliation":[{"name":"Section of Paediatric Gastroenterology, Department of Paediatrics, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Goedhart","sequence":"additional","affiliation":[{"name":"Section of Paediatric Gastroenterology, Department of Paediatrics, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otto G","family":"Vanderkooi","sequence":"additional","affiliation":[{"name":"Section of Infectious Diseases, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Pathology & Laboratory Medicine, University of Calgary, Calgary, Alberta, Canada"},{"name":"Department of Microbiology, Immunology and Infectious Diseases, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Wrobel","sequence":"additional","affiliation":[{"name":"Section of Paediatric Gastroenterology, Department of Paediatrics, University of Calgary, Calgary, Alberta, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,12,14]]},"reference":[{"key":"2019061807195877100_CIT0001","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet."},{"key":"2019061807195877100_CIT0002","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/ibd.20121","article-title":"Intercenter variation in initial management of children with Crohn\u2019s disease","volume":"13","author":"Kappelman","year":"2007","journal-title":"Inflamm Bowel Dis."},{"key":"2019061807195877100_CIT0003","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1002\/ibd.21591","article-title":"Changes to surgical and hospitalization rates of pediatric inflammatory bowel disease in Ontario, Canada (1994-2007)","volume":"17","author":"Benchimol","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"2019061807195877100_CIT0004","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1111\/j.1572-0241.2004.41389_7.x","article-title":"Disseminated primary varicella after initiation of infliximab for Crohn\u2019s disease","volume":"99","author":"Leung","year":"2004","journal-title":"Am J Gastroenterol."},{"key":"2019061807195877100_CIT0005","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1136\/gut.2004.040675","article-title":"Chronic hepatitis B reactivation following infliximab therapy in Crohn\u2019s disease patients: need for primary prophylaxis","volume":"53","author":"Esteve","year":"2004","journal-title":"Gut."},{"key":"2019061807195877100_CIT0006","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1097\/00054725-200409000-00028","article-title":"Guidelines for immunizations in patients with inflammatory bowel disease","volume":"10","author":"Sands","year":"2004","journal-title":"Inflamm Bowel Dis."},{"key":"2019061807195877100_CIT0007","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1002\/ibd.20943","article-title":"Vaccination strategies for patients with inflammatory bowel disease on immunomodulators and biologics","volume":"15","author":"Melmed","year":"2009","journal-title":"Inflamm Bowel Dis."},{"key":"2019061807195877100_CIT0008","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1016\/j.vaccine.2017.09.031","article-title":"Vaccination strategies in pediatric inflammatory bowel disease","volume":"35","author":"Dipasquale","year":"2017","journal-title":"Vaccine."},{"key":"2019061807195877100_CIT0009","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1038\/ajg.2017.97","article-title":"Trends in epidemiology of pediatric inflammatory bowel disease in Canada: distributed network analysis of multiple population-based provincial health administrative databases","volume":"112","author":"Benchimol","year":"2017","journal-title":"Am J Gastroenterol."},{"issue":"11(Pt 2","key":"2019061807195877100_CIT0010","first-page":"3","article-title":"Sero-epidemiology of the Epstein-Barr virus: preliminary analysis of an international study - a review","author":"de-Th\u00e9","year":"1975","journal-title":"IARC Sci Publ."},{"key":"2019061807195877100_CIT0011","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1086\/508173","article-title":"Seroprevalence of cytomegalovirus infection in the United States, 1988-1994","volume":"43","author":"Staras","year":"2006","journal-title":"Clin Infect Dis."},{"key":"2019061807195877100_CIT0012","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/gast.2002.30328","article-title":"Epstein-Barr virus-positive lymphoma in patients with inflammatory bowel disease treated with azathioprine or 6-mercaptopurine","volume":"122","author":"Dayharsh","year":"2002","journal-title":"Gastroenterology."},{"key":"2019061807195877100_CIT0013","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1002\/ibd.21582","article-title":"Risk of malignant lymphoma in patients with inflammatory bowel diseases: a Dutch nationwide study","volume":"17","author":"Vos","year":"2011","journal-title":"Inflamm Bowel Dis."},{"key":"2019061807195877100_CIT0014","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1053\/j.gastro.2017.02.004","article-title":"Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease","volume":"152","author":"Hyams","year":"2017","journal-title":"Gastroenterology."},{"key":"2019061807195877100_CIT0015","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jpeds.2011.04.045","article-title":"Association of Crohn\u2019s disease, thiopurines, and primary Epstein-Barr virus infection with hemophagocytic lymphohistiocytosis","volume":"159","author":"Biank","year":"2011","journal-title":"J Pediatr."},{"key":"2019061807195877100_CIT0016","doi-asserted-by":"crossref","first-page":"3399","DOI":"10.1007\/s10620-015-3764-z","article-title":"Seroprevalence of Epstein-Barr virus, cytomegalovirus, and polyomaviruses in children with inflammatory bowel disease","volume":"60","author":"Hradsky","year":"2015","journal-title":"Dig Dis Sci."},{"key":"2019061807195877100_CIT0017","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1016\/0016-5085(85)90011-3","article-title":"Defective generation of tetanus-specific antibody-producing B cells after in vivo immunization of Crohn\u2019s disease and ulcerative colitis patients","volume":"88","author":"Stevens","year":"1985","journal-title":"Gastroenterology."},{"key":"2019061807195877100_CIT0018","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ibd.21706","article-title":"Immunogenicity and safety of influenza vaccination in children with inflammatory bowel disease","volume":"18","author":"deBruyn","year":"2012","journal-title":"Inflamm Bowel Dis."},{"key":"2019061807195877100_CIT0019","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/MPG.0b013e31805563f3","article-title":"Differentiating ulcerative colitis from Crohn\u2019s disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn\u2019s and Colitis Foundation of America","volume":"44","author":"Bousvaros","year":"2007","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2019061807195877100_CIT0020","volume-title":"Government of Alberta Health and Wellness"},{"key":"2019061807195877100_CIT0021","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1471-230X-11-87","article-title":"An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease","volume":"11","author":"Crawford","year":"2011","journal-title":"BMC Gastroenterol."},{"key":"2019061807195877100_CIT0022","article-title":"Immunization coverage in children with inflammatory bowel disease","author":"Kowalska-Duplaga","year":"","journal-title":"Adv Exp Med Biol."},{"key":"2019061807195877100_CIT0023","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1155\/2013\/539524","article-title":"Immunization history of children with inflammatory bowel disease","volume":"27","author":"Soon","year":"2013","journal-title":"Can J Gastroenterol."},{"key":"2019061807195877100_CIT0024","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/ibd.23027","article-title":"Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD","volume":"19","author":"Naganuma","year":"2013","journal-title":"Inflamm Bowel Dis."},{"key":"2019061807195877100_CIT0025","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2036.2012.05150.x","article-title":"Prior varicella zoster virus exposure in IBD patients treated by anti-TNFs and other immunomodulators: implications for serological testing and vaccination guidelines","volume":"36","author":"Kopylov","year":"2012","journal-title":"Aliment Pharmacol Ther."},{"key":"2019061807195877100_CIT0026","doi-asserted-by":"crossref","first-page":"S147","DOI":"10.1086\/529448","article-title":"Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella","volume":"197","author":"Breuer","year":"2008","journal-title":"J Infect Dis."},{"key":"2019061807195877100_CIT0027","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/MPG.0b013e31821e1917","article-title":"Varicella immunity in inflammatory bowel disease","volume":"53","author":"Ansari","year":"2011","journal-title":"J Pediatr Gastroenterol Nutr."},{"key":"2019061807195877100_CIT0028","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/ajg.2011.295","article-title":"Hepatitis B immunity and response to booster vaccination in children with inflammatory bowel disease treated with infliximab","volume":"107","author":"Moses","year":"2012","journal-title":"Am J Gastroenterol."},{"key":"2019061807195877100_CIT0029","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/01.inf.0000109287.97518.67","article-title":"Ten year follow-up of healthy children who received one or two injections of varicella vaccine","volume":"23","author":"Kuter","year":"2004","journal-title":"Pediatr Infect Dis J."},{"key":"2019061807195877100_CIT0030","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.vaccine.2012.11.037","article-title":"Antibody persistence and the effect of a booster dose given 5, 10 or 15 years after vaccinating preadolescents with a recombinant hepatitis B vaccine","volume":"31","author":"Gilca","year":"2013","journal-title":"Vaccine."},{"key":"2019061807195877100_CIT0031","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1136\/annrheumdis-2011-200637","article-title":"Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study","volume":"71","author":"Heijstek","year":"2012","journal-title":"Ann Rheum Dis."},{"key":"2019061807195877100_CIT0032","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s00431-011-1569-4","article-title":"Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children","volume":"171","author":"Knuf","year":"2012","journal-title":"Eur J Pediatr."},{"key":"2019061807195877100_CIT0033","doi-asserted-by":"crossref","first-page":"4644","DOI":"10.1016\/S0264-410X(01)00239-0","article-title":"Measles seroepidemiology and decay rate of vaccine-induced measles igg titers in Taiwan, 1995-1997","volume":"19","author":"Lee","year":"2001","journal-title":"Vaccine."},{"key":"2019061807195877100_CIT0034","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s10620-011-1980-8","article-title":"Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls","volume":"57","author":"Altun\u00f6z","year":"2012","journal-title":"Dig Dis Sci."},{"key":"2019061807195877100_CIT0035","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/j.vaccine.2011.11.109","article-title":"Are immunosuppressive medications associated with decreased responses to routine immunizations? A systematic review","volume":"30","author":"Agarwal","year":"2012","journal-title":"Vaccine."},{"key":"2019061807195877100_CIT0036","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1016\/j.dld.2015.07.120","article-title":"EBV and CMV status in children with IBD at diagnosis: a case control study","volume":"47","author":"Annibali","year":"2015","journal-title":"Dig Liver Dis."},{"key":"2019061807195877100_CIT0037","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/apt.12558","article-title":"Letter: Epstein-Barr virus status may be especially important in paediatric IBD populations","volume":"39","author":"Love","year":"2014","journal-title":"Aliment Pharmacol Ther."},{"key":"2019061807195877100_CIT0038","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1111\/apt.12503","article-title":"Prevalence of Epstein-Barr virus in a population of patients with inflammatory bowel disease: a prospective cohort study","volume":"38","author":"Linton","year":"2013","journal-title":"Aliment Pharmacol Ther."},{"key":"2019061807195877100_CIT0039","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1086\/652438","article-title":"Cytomegalovirus seroprevalence in the United States: the National Health and Nutrition Examination Surveys, 1988-2004","volume":"50","author":"Bate","year":"2010","journal-title":"Clin Infect Dis."},{"key":"2019061807195877100_CIT0040","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1128\/CVI.00203-06","article-title":"National serosurvey of cytomegalovirus in Australia","volume":"13","author":"Seale","year":"2006","journal-title":"Clin Vaccine Immunol."},{"key":"2019061807195877100_CIT0041","doi-asserted-by":"crossref","first-page":"e64921","DOI":"10.1371\/journal.pone.0064921","article-title":"Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6\u201319, 2003\u20132010","volume":"8","author":"Dowd","year":"2013","journal-title":"PLoS One."},{"key":"2019061807195877100_CIT0042","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1007\/s10620-008-0639-6","article-title":"Acute cytomegalovirus infection is a risk factor in refractory and complicated inflammatory bowel disease","volume":"54","author":"Maher","year":"2009","journal-title":"Dig Dis Sci."}],"container-title":["Inflammatory Bowel Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ibdjournal\/article-pdf\/25\/7\/1218\/28837006\/izy366.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,8]],"date-time":"2022-09-08T09:28:45Z","timestamp":1662629325000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ibdjournal\/article\/25\/7\/1218\/5247477"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12,14]]},"references-count":42,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2018,12,14]]},"published-print":{"date-parts":[[2019,6,18]]}},"URL":"https:\/\/doi.org\/10.1093\/ibd\/izy366","relation":{},"ISSN":["1078-0998","1536-4844"],"issn-type":[{"value":"1078-0998","type":"print"},{"value":"1536-4844","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,7]]},"published":{"date-parts":[[2018,12,14]]}}}